|
|
| | Capecitabinealfa alfa impurity2 Basic information |
| Product Name: | Capecitabinealfa alfa impurity2 | | Synonyms: | Capecitabinealfa alfa impurity2;Capecitabine impurity 11/N-[1-(2,3-Di-O-acetyl-5-deoxy-alpha-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]carbamic acid pentyl ester;Capecitabine Impurity 17;N-[1-(2,3-di-O-acetyl-5-deoxy-α-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-, pentyl ester carbamic acid;Carbamic acid, N-[1-(2,3-di-O-acetyl-5-deoxy-α-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-, pentyl ester | | CAS: | 1810778-34-7 | | MF: | C19H26FN3O8 | | MW: | 443.43 | | EINECS: | | | Product Categories: | | | Mol File: | 1810778-34-7.mol |  |
| | Capecitabinealfa alfa impurity2 Chemical Properties |
| density | 1.40±0.1 g/cm3(Predicted) | | pka | 5.36±0.40(Predicted) |
| | Capecitabinealfa alfa impurity2 Usage And Synthesis |
| Uses | N-[1-(2,3-di-O-acetyl-5-deoxy-α-D-ribofuranosyl)-5-fluoro-1,2-dihydro-2-oxo-4-pyrimidinyl]-, pentyl ester carbamic acid is a derivative of Capecitabine (C175650), an antineoplastic agent and a prodrug of Doxifluridine (D556750). |
| | Capecitabinealfa alfa impurity2 Preparation Products And Raw materials |
|